Clinical Trial Update: Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase II study of VcR-CVAD with rituximab consolidation and maintenance for untreated mantle cell lymphoma has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)
• VcR-CVAD

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2011-02-15